BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Duke JA, Paschall AV, Robinson LS, Knoot CJ, Vinogradov E, Scott NE, Feldman MF, Avci FY, Harding CM. Development and Immunogenicity of a Prototype Multivalent Group B Streptococcus Bioconjugate Vaccine. ACS Infect Dis 2021;7:3111-23. [PMID: 34633812 DOI: 10.1021/acsinfecdis.1c00415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Liu J. Group B Streptococcus: Virulence Factors and Pathogenic Mechanism. Microorganisms 2022;10. [PMID: 36557736 DOI: 10.3390/microorganisms10122483] [Reference Citation Analysis]
2 Knoot CJ, Wantuch PL, Robinson LS, Rosen DA, Scott NE, Harding CM. Discovery and characterization of a new class of O-linking oligosaccharyltransferases from the Moraxellaceae family. Glycobiology 2023;33:57-74. [PMID: 36239418 DOI: 10.1093/glycob/cwac070] [Reference Citation Analysis]
3 Aceil J, Paschall AV, Knoot CJ, Robinson LS, Scott NE, Feldman MF, Harding CM, Avci FY. Immunogenicity and protective efficacy of a prototype pneumococcal bioconjugate vaccine. Vaccine 2022;40:6107-13. [PMID: 36115800 DOI: 10.1016/j.vaccine.2022.09.018] [Reference Citation Analysis]